Glenmark and Granules India shares rose Monday, hitting fresh highs after both drugmakers landed key US regulatory approvals. Both moves were driven by news out...
Zydus Lifesciences jumps to Rs 1,125 on 29 June, up 2%, after extending its Sterling Biotech API acquisition deadline to 30 September 2026. Active Pharmaceutical...